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Abstract
Background: Guidelines on the management of aneurysmal subarachnoid hemorrhage (aSAH) recommend euvolemia, whereas
hypervolemia may cause harm. We investigated whether high early fluid input is associated with delayed cerebral ischemia (DCI),
and if fluid input can be safely decreased using transpulmonary thermodilution (TPT). Methods: We retrospectively included
aSAH patients treated at an academic intensive care unit (2007-2011; cohort 1) or managed with TPT (2011-2013; cohort 2).
Local guidelines recommended fluid input of 3 L daily. More fluids were administered when daily fluid balance fell belowþ500 mL.
In cohort 2, fluid input in high-risk patients was guided by cardiac output measured by TPT per a strict protocol. Associations of
fluid input and balance with DCI were analyzed with multivariable logistic regression (cohort 1), and changes in hemodynamic
indices after institution of TPT assessed with linear mixed models (cohort 2). Results: Cumulative fluid input 0 to 72 hours after
admission was associated with DCI in cohort 1 (n=223; odds ratio [OR] 1.19/L; 95% confidence interval 1.07-1.32), whereas
cumulative fluid balance was not. In cohort 2 (23 patients), using TPT fluid input could be decreased from 6.0+ 1.0 L before to 3.4
+ 0.3 L; P ¼ .012), while preload parameters and consciousness remained stable. Conclusion: High early fluid input was
associated with DCI. Invasive hemodynamic monitoring was feasible to reduce fluid input while maintaining preload. These results
indicate that fluid loading beyond a normal preload occurs, may increase DCI risk, and can be minimized with TPT.
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Introduction
Delayed cerebral ischemia (DCI) after aneurysmal subarach-
noid hemorrhage (aSAH) affects approximately 30% of
patients.1 DCI typically develops between days 4 and 14 after
ictus2 and may progress to cerebral infarction which is associ-
ated with poor outcome.3,4 Since hypovolemia is associated
with DCI, standard management includes maintenance of
euvolemia.5,6 Nevertheless, ascertainment of euvolemia is pro-
blematic in clinical practice but highly relevant for several
reasons. Guidelines recommend using meticulous fluid balance
monitoring to guide fluid management. However, fluid balance
has been shown to be poorly indicative of volume status.7 In
addition, euvolemia as a fluid management goal is subject to
interpretation, which is illustrated by highly variable mainte-
nance fluid practices in aSAH across neurocritical care units.8-
10 In clinical practice, many patients with aSAH receive exces-
sive fluids, with the aim to maintain a positive fluid balance.
However, excessive fluid administration may result in more
systemic complications (eg, congestive heart failure and pul-
monary deterioration).11-13 In addition, a recent overview of
the current literature suggested that excessive fluids might also
be detrimental to neurological outcomes.10 In contrast, hyper-
volemic therapy—as part of triple-H therapy—has long been
regarded as beneficial rather than potentially harmful in
aSAH.10 Hypervolemia, which may be defined as fluid input
exceeding the amount necessary for adequate organ perfusion,
may therefore be an ill-recognized cause of harm to the brain.
Since fluid management in aSAH still relies importantly on
fluid balance, it is clinically relevant to assess whether exces-
sive fluids are beneficial or harmful with regard to neurological
clinical course. When “hypervolemia” as defined above is a
frequently occurring and undesirable consequence of aiming
for positive fluid balances, one may hypothesize that hemody-
namic monitoring may help restricting fluid input without com-
promising adequate cardiac preload and cerebral blood flow.
The main objective of this study was therefore to investigate
whether high early fluid input and fluid balances within 72 hours
after admission are associated with the occurrence of DCI in
patients with aSAH. Our secondary objective was to report on
the feasibility of decreasing fluid input guided by cardiac output
monitoring with transpulmonary thermodilution (TPT).
Materials and Methods
Study Design and Population
In this report, we describe 2 thematically related but separate
studies. A schematic representation of the design and aims of
the separate cohorts is shown in Figure 1. The first study was a
retrospective cohort study of consecutively admitted patients
with aSAH (cohort 1) to the intensive care unit (ICU) of a
university hospital (Erasmus MC, University Medical Center,
Rotterdam, the Netherlands) between October 2007 and Octo-
ber 2011, aiming to investigate whether high early fluid input
or positive fluid balances were associated with DCI. Because
preliminary analyses of cohort 1 showed that high early fluid
input was associated with DCI,14 we instituted a fluid manage-
ment protocol using fluid responsiveness with TPT using the
PiCCO device (Pulsion Medical Systems SE, Feldkirchen, Ger-
many), assuming that a reduction in excessive fluid input while
maintaining adequate cardiac preload might be possible. The
second study (cohort 2) concerned the first series of patients
with aSAH (April 2011-September 2013, admitted to the same
unit) managed with this newly instituted TPT protocol (Supple-
mental File A) and was aimed at retrospectively assessing
changes in fluid input and balances in the days before versus
after TPT.
The inclusion criteria for cohort 1 were 18 years or older,
aSAH, and admission to hospital 48 hours after ictus. The
exclusion criteria were heart failure known from medical his-
tory, renal insufficiency (creatinine > 150 mmol/L), pregnancy,
and death within 48 hours after admission. For cohort 2, the
inclusion criteria were similar to the indications for TPT mon-
itoring according to the fluid management protocol and con-
cerned high-risk patients (detailed in Supplemental Files A and
B). Briefly, these criteria concerned lower than expected blood
pressure or highly negative fluid balance, signs of pulmonary
or cardiac dysfunction, or progressive neurological deteriora-
tion due to DCI. Patients in both cohorts were identified
through a hospital health service code indicating subarachnoid
hemorrhage. Institutional medical ethics committee approval
for both cohort studies was obtained and informed consent was
not necessary, given the observational nature of the studies and
anonymization of patient data in accordance with Dutch legis-
lation. Due to the retrospective nature, we did not perform a
power analysis and used a sample size of convenience.
Diagnosis and Patient Management
All patients were routinely managed at an ICU. In both cohorts,
patients were evaluated with head computed tomography (CT)
and CT angiography on admission. When no blood was seen on
Figure 1. Schematic representation of the study design. TPT, trans-
pulmonary thermodilution; aSAH, acute subarachnoid hemorrhage;
ICU, intensive care unit; CVP, central venous pressure; CI, cardiac
index; SVI, stroke volume index; EVLWI, extravascular lung water
index; GEDVI, global end-diastolic volume index.
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CT, a lumbar puncture was performed >12 hours after ictus for
spectrophotometric analysis of cerebrospinal fluid (CSF). Dur-
ing the inclusion period for cohort 1, coiling procedures were
performed by a regional team of interventional neuroradiolo-
gists. Stable patients were temporarily transferred to a different
hospital for endovascular treatment when an interventional
neuroradiologist was not available within 24 hours in the
admitting hospital (Erasmus MC). A detailed description of
patient management during the ICU admission in the 2 cohorts
is given in Supplemental File B.
Data Collection and Outcomes
For both cohorts, data were collected from the ICU patient data
management system and electronic patient records. Fluid input
included all infusion fluids (including pharmaceuticals, blood
products, and intraoperative fluids), tube feeding, and normal
diet. Fluid losses included urine output, intraoperative blood
loss, gastrointestinal losses, and CSF from intrathecal drains.
Insensible loss was not accounted for in the analyses. Fluid
balance was calculated by subtracting fluid loss from input.
In cohort 1, fluid input, loss, and balance were collected for
the first 3 days after admission (day 1: 0-24 hours, day 2: 24-48
hours, and day 3: 48-72 hours). Admission CT scans were
evaluated for Hijdra sum scores.15 The primary outcome was
DCI defined by CT infarction, clinical deterioration, or both
without other cause, according to recently proposed consensus
criteria.1,16 Two authors (L.J.M.V. and M.v.d.J.) assessed the
primary outcome. During outcome assessments, the authors
were blinded to the daily fluid data. Consensus on the outcomes
was obtained by discussion in case of initial disagreement.
Glasgow outcome score (GOS) was assessed between 3 and
6 months after admission to the hospital as a secondary out-
come. When GOS could not be retrieved from our electronic
patient records, we sent a letter to the general practitioner to
request the relevant information.
In cohort 2, fluid data and Glasgow coma score (GCS) were
collected over a period from 3 days before until 3 days after
TPT initiation. The TPT parameters—cardiac index (CI),
stroke volume index (SVI), global end-diastolic volume index
(GEDVI), and extravascular lung water index (EVLWI)—were
collected during the study period and the daily average values
recorded. Central venous pressure (CVP) measurements were
collected at least from the day before TPT initiation until 3 days
after. In this cohort, DCI was assessed as defined in cohort 1 by
1 author (M.E.) who was blinded for other clinical data. In
contrast to cohort 1, the primary outcome was the difference
in fluid parameters before versus after the start of TPT
monitoring.
Statistical Analysis
Data were summarized as number with percentage (categori-
cal), as median with interquartile range (ordinal), and as mean
(standard error; continuous). Imputation of missing values in
the fluid parameters and Hijdra sum scores in cohort 1 was
performed with single imputation with regression based on
relevant covariates and outcome (Supplemental File C).
Patients with DCI and without DCI in cohort 1 were compared
using the Student t test, Mann-Whitney U test, chi-square test,
or Fisher exact test. In cohort 1, logistic regression models were
created with cumulative fluid input or cumulative fluid balance
during the first 24, 48, and 72 hours of ICU admission and
previously identified independent predictors of DCI (age,
gender, World Federation of Neurosurgical Societies [WFNS]
grading score at admission, and Hijdra sum scores on initial CT
scan)17,18 as covariables. Hijdra scores were dichotomized at
their median, and WFNS was dichotomized into good (WFNS,
1-3) and poor (WFNS, 4-5) grades for the analyses. Sensitivity
analyses with cerebral infarction on CT due to DCI with or
without clinical signs and a secondary analysis with GOS as
outcome were performed. Interaction between variables was
assessed in each model. To assess whether the relation between
fluid input and balance was nonlinear, that is, whether there was
a specific cutoff in the effect of fluid on outcome, we did similar
analyses with fluid input as covariables dichotomized on a
cutoff of 3, 4, and 5 L daily. In cohort 2, fluid and hemodynamic
parameters were compared before and after TPT using linear
mixedmodels, with day 3 after initiation of TPT as the reference.
The course of patients’ GCSs before and after TPT was assessed
with Wilcoxon signed rank test. A 2-sided P value of<.05 was
considered statistically significant. All statistical analyses were
performed using SPSS 20.0.0 (IBM, Chicago, Illinois).
Results
Cohort 1
We included 223 consecutive patients with aSAH, of whom 91
(41%) developed DCI. General characteristics of patients with
and without DCI are reported in Table 1. In total, 119 observa-
tions (18%) of fluid input data, 119 observations (18%) of fluid
loss data, 8 (3.6%) Hijdra cistern sum scores, and 12 (5.4%) of
Hijdra ventricle sum scores were missing and imputed. Mean
hemoglobin (Hb) level at days 2 and 3 was lower, and blood
pressure at day 1 was higher in patients who developed DCI
versus those who did not.
In patients who later developed DCI, fluid input was higher
on day 1 (DCI: 4.9+ 0.19 L; no DCI: 4.4+ 0.13 L; P¼ .005)
and day 2 after admission (DCI: 5.0+ 0.21 L; no DCI: 4.2+
0.12 L; P ¼ .004; Figure 2). Fluid balance did not differ
between groups. In multivariable logistic regression models,
cumulative fluid input was associated with an increased risk
of DCI (0-24 hours: odds ratio [OR] 1.22/L, 95% confidence
interval [CI] 1.01-1.46; 0-48 hours: OR 1.26/L, 95% CI 1.10-
1.44; and 0-72 hours: OR 1.19/L, 95% CI 1.07-1.32; Table 2).
There was no association between cumulative fluid balances
and DCI (0-24 hours: OR 1.09/L, 95% CI 0.90-1.32; 0-48
hours: OR 1.07/L, 95% CI 0.95-1.21; and 0-72 hours: OR
1.06/L, 95% CI 0.97-1.17). The logistic regression models
including fluid input dichotomized at 3, 4, or 5 L are reported
in Supplemental File D. Higher fluid input was still associated
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with increased risk of DCI in these analyses, although specific
cutoffs were not evident. The univariable analysis for the fluid
variables is shown in Supplemental File E. Adding Hb level
and blood pressure as covariables to the multivariable analyses
did not change the associations between fluid intake and DCI
(data not shown). No significant interactions were found
between the independent variables.
The sensitivity analysis with DCI infarction as the outcome
yielded similar results as those with DCI, but cumulative fluid
balances at 0 to 48 and 0 to 72 hours after admission were
associated with cerebral infarction due to DCI (0-48 hours:
OR 1.15/L, 95% CI 1.00-1.33, and 0-72 hours: OR 1.12/L,
95% CI 1.01-1.25; Supplemental File F). Secondary outcome
analysis for GOS showed results similar to the analysis for fluid
input and DCI (Supplemental File G).
Cohort 2
We included the first 23 patients with aSAH who had an indi-
cation for TPT according to the protocol (Supplemental File
A). Table 3 shows some pertinent characteristics on demo-
graphics, aneurysm management, and outcomes. Eleven
patients (48%) died within 30 days after ICU admission, and
this high mortality relates to the inclusion of high-risk patients
for TPT, including those with recent signs of DCI. Fluid data
from day 3 to day 3 relative to TPT initiation were available
for 11, 10, 21, 23, 21, 20, and 20 patients, respectively (eg, only
11/23 patients had been admitted with available fluid data, 3
days before TPT initiation).
Daily fluid parameters and daily GCS are shown in Figure 3.
Compared to day 3 (reference) after TPT initiation (fluid input:
3.4+ 0.3 L), fluid input was higher on day2 (6.0+ 1.0 L; P
Table 1. General Characteristics of Cohort 1.a
Variable No DCI DCI P
N 132 91
Female 82 (62) 61 (67) .480
Age (year) 55+ 1.1 57 + 1.5 .289
Loss of consciousness at ictus 53 (41) 55 (61) .003
ICU admission within 24 hours 125 (95) 85 (94) .761
Admission GCS 14 (13-15) 13 (6-15) .001
Transferred for intervention
within 72 hours
59 (45) 29 (32) .054
Aneurysm location
Anterior circulation 101 (77) 72 (79) .744
Posterior circulation 23 (17) 17 (19) .860
No aneurysm found 8 (6) 2 (2) .206
Hijdra cistern sum score 16 (9-20) 20 (14-23) .001
Hijdra ventricular sum score 2 (0-4) 3 (0-6) .010
Treatment day 1.8+ 0.2 2.0+ 0.4 .911
Aneurysm treatment mode
Coiling 85 (64) 44 (48) .019
Clipping 31 (24) 25 (28) .532
No occlusion 16 (12) 22 (24) .029
Day of DCI diagnosis 8 + 0.5
DCI diagnosis based on
CT only 34 (37)
Clinical signs only 31 (34)
Both CT and clinical signs 26 (29)
Daily mean arterial pressure
(mm Hg)
Day 1 93.7+ 1.1 99.3 + 1.4 .002
Day 2 97.2+ 1.2 101.0 + 1.8 .072
Day 3 101.0+ 1.3 104.0 + 1.7 .170
Mean hemoglobin (mmol/L)
Day 1 7.97+ 0.08 7.82 + 0.10 .251
Day 2 7.45+ 0.08 7.15 + 0.13 .050
Day 3 7.35+ 0.09 6.95 + 0.10 .009
Mean heart rate (beats per
minute)
Day 1 71.8+ 1.1 73.8 + 1.5 .303
Day 2 69.7+ 1.1 71.4 + 1.7 .389
Day 3 71.5+ 1.2 72.8 + 1.7 .535
Lowest peripheral oxygen
saturation (%)
Day 1 89.8+ 0.95 89.6 + 0.98 .875
Day 2 92.7+ 0.52 91.7 + 0.88 .336
Day 3 91.6+ 0.58 91.6 + 0.58 .943
GOS follow-up (months) 3.5+ 0.1 2.8+ 0.2 .008
GOS <.001
Death 11 (9) 33 (39)
Persistent vegetative state 0 1 (1)
Severe disability,
dependent
2 (2) 16 (19)
Moderate disability,
independent
21 (17) 10 (12)
Good recovery 88 (72) 25 (29)
6-month mortality 11 (9) 33 (38) <.001
Abbreviations: DCI, delayed cerebral ischemia; ICU, intensive care unit; GCS,
Glasgow coma score; CT, computed tomography; GOS, Glasgow outcome
scale.
aData are reported as mean+ standard error, median (interquartile range), or
number (percentage) where appropriate.
Figure 2. Daily fluid parameters in cohort 1. Data are represented as
mean with 95% CI as 1-sided error bar. Differences between patients
with and without DCI are indicated in figures: *P < .01. ICU, intensive
care unit; DCI, delayed cerebral ischemia; CI, confidence interval.
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¼ .012) and day 1 (5.3+ 0.9 L; P ¼ .008). Daily fluid loss
was lower on day 3 when compared to day 3 (2.7+ 0.5 L vs
3.4 + 0.4 L; P ¼ .049). As a result, daily fluid balance was
higher on day 3 (1.8+ 0.6 L; P ¼ .003), day 2 (2.9+ 1.4
L; P < .001), and day 1 (1.4 + 0.4 L; P ¼ .014) when
compared to day 3 (0.0 + 0.2 L). Median daily GCS on day
1 was not significantly lower than the median daily GCS on
day 3 (GCS of 7 [5.5-7.5] vs 9 [6-14]; P ¼ .18). Most hemo-
dynamic parameters as measured during TPT (CVP, CI, and
SVI) remained within the range of normal values in spite of
significant reductions in fluid input and balances after start of
TPT, except GEDVI and EVLWI which were higher than the
normal ranges of 650 to 800 mL/m2 and 3.0 to 7.0 mL/kg,
respectively (Supplemental File H).
Discussion
The main finding of this study in patients with aSAH is that
early high daily fluid input was independently associated with
DCI and poor outcome. In addition, we showed that fluid load-
ing beyond normal preload occurred in clinical practice and
that it was feasible to significantly restrict fluid input while
maintaining adequate preload with TPT in selected high-risk
patients with aSAH. Taken together, these results corroborate
the potential harm from fluid overload in patients with aSAH
with regard to DCI and support further study on potential ben-
efit of fluid restriction guided by hemodynamic monitoring.
We found that early high fluid input was associated with
DCI. However, our cohort data, and specifically the analyses
for fluid input of 3, 4, or 5 L daily, did not indicate a specific
cutoff for fluid input beyond which DCI risk was increased.
Therefore, firm conclusions about upper limits of fluid input
for this cohort are not possible in spite of the robust finding that
more fluids associate with DCI risk, indicating that fluid titra-
tion in aSAH should still be individualized. In a sensitivity
analysis with cerebral infarction on CT as the outcome, positive
net fluid balances also showed an association. Furthermore, the
hemodynamic data in cohort 2 seem to indicate a state of
hypervolemia, since GEDVI was higher than reference values.
There are several possible explanations why high fluid input is
associated with DCI.10 First, increased “fluid throughput” may
cause fluids to accumulate in the interstitial space when the
Table 2. Multivariable Logistic Regression Models for Cumulative Fluid Input and Balance Data From Cohort 1 with DCI as Outcome.
Fluid Input Fluid Balance
Variable OR 95% CI Variable OR 95% CI
Age (year) 1.01 0.99-1.04 Age (year) 1.01 0.99-1.03
Gender (female) 1.33 0.73-2.43 Gender (female) 1.24 0.69-2.24
Admission WFNS (>3) 2.30 1.24-4.27 Admission WFNS (>3) 2.62 1.43-4.81
Hijdra cistern score (17) 2.23 1.25-3.98 Hijdra cistern score ( 17) 2.17 1.22-3.86
Hijdra ventricular score (2) 1.11 0.60-2.05 Hijdra ventricular score ( 2) 1.14 0.62-2.10
Fluid input 0-24 hour L 1.22 1.01-1.46 Fluid balance 0-24 hour (L) 1.09 0.90-1.32
Age (year) 1.01 0.99-1.04 Age (year) 1.01 0.99-1.03
Gender (female) 1.33 0.72-2.45 Gender (female) 1.24 0.68-2.23
Admission WFNS (>3) 2.25 1.21-4.20 Admission WFNS (>3) 2.54 1.39-4.66
Hijdra cistern score (17) 2.22 1.23-3.99 Hijdra cistern score (17) 2.15 1.21-3.81
Hijdra ventricular score (2) 1.14 0.61-2.12 Hijdra ventricular score (2) 1.15 0.63-2.10
Fluid input 0-48 hour (L) 1.26 1.10-1.44 Fluid balance 0-48 hour (L) 1.07 0.95-1.21
Age (year) 1.01 0.99-1.04 Age (year) 1.01 0.99-1.03
Gender (female) 1.39 0.75-2.58 Gender (female) 1.24 0.69-2.25
Admission WFNS (>3) 2.45 1.31-4.56 Admission WFNS (>3) 2.50 1.36-4.59
Hijdra cistern score (17) 2.27 1.26-4.08 Hijdra cistern score ( 17) 2.20 1.24-3.91
Hijdra ventricular score (2) 1.17 0.63-2.18 Hijdra ventricular score ( 2) 1.11 0.60-2.04
Fluid input 0-72 hour (L) 1.19 1.07-1.32 Fluid balance 0-72 hour (L) 1.06 0.97-1.17
Abbreviations: WFNS: World Federation of Neurosurgical Societies grading score; OR, odds ratio; CI, confidence interval.
Table 3. General Characteristics at Start of Invasive Hemodynamic
Monitoring in Cohort 2.
Variable
N 23
Female 19 (83)
Age (year) 55+ 3.4
GCS 8 (6-13)
DCI (infarction, clinical, and both) 10 (44)
Hijdra cistern sum score 14.6+ 1.2
Hijdra ventricular sum score 4.4 + 0.9
Treatment mode
Coiling 9 (39)
Clipping 11 (48)
No occlusion 3 (13)
IHM initiated (days after admission) 1.4 + 0.4
30-day mortality 11 (48)
Abbreviations: DCI, delayed cerebral ischemia; GCS, Glasgow coma score;
IHM, invasive hemodynamic monitoring by transpulmonary thermodilution.a
Data are reported as mean+ standard error, median (interquartile range), or
number (percentage) where appropriate.
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blood–brain barrier is damaged, which may impede local oxy-
gen diffusion to neurons.19-21 Second, hemodilution as a con-
sequence of fluid loading may decrease shear stress in the
cerebral arteries, which may be detrimental to the integrity of
the blood–brain barrier,22 and lower Hb levels may contribute
to DCI due to decreased oxygen transport capacity of the blood,
in line with our findings. Lastly, in cohort 1, as fluid input
increased, fluid loss did not increase equally to match the
higher fluid input (data not shown). Conversely, in cohort 2,
when fluid input decreased, diuresis seemed to increase. Both
observations may theoretically be explained by (renal) venous
congestion (ie, high CVP).23 It has been postulated that venous
congestion may also impede cerebral venous outflow and lead
to intracranial pressure increase.24 Furthermore, several studies
in brain injured critically ill patients have found CVP to be
higher in patients with worse neurological outcomes.11,13,25
Similarly, a recent study found that higher CVP was associated
with lower brain tissue oxygen saturation and worse outcome in
postcardiac arrest patients.26 We acknowledge that these data
do not provide proof and should be considered as hypothesis
generating, with regard to the pathophysiologic role of venous
congestion in DCI due to excessive fluids.
Our findings substantiate previous findings. Several inves-
tigators have described early mean daily fluid input varying
from 3.3 to 6.6 L and daily fluid balances varying from 0.6
to þ2.1 L.7,25,27-30 However, studies investigating the relation
between fluid management and DCI are scarce.25,29,31,32 Two
studies investigating the effect of early goal-directed hemody-
namic management reported that mean daily fluid input was 2.7
L in the first 3 days with mean fluid balances between0.5 and
0.5 L when using TPT.33,34 Using goal-directed hemodynamic
management, less fluid was infused and fewer patients had DCI
than in the conventional treatment group in line with our find-
ings.34 The association of fluid input but not fluid balance with
DCI is also in line with previous reports.28,33
Some limitations of our study should be considered. Due to
the retrospective nature, potential unmeasured confounding
factors and retrieval of relevant patient data are an inherent
threat to the associations found in cohort 1. Consequently,
causality between high fluid input and DCI cannot be proven
Figure 3. Daily fluid parameters and associated course of GCS in cohort 2. Data are represented as mean with standard error as 1-sided error
bar and median with interquartile range for GCS. The TPT day 3 is used as the reference value (R) for the comparisons. þP < .05; *P < .01; **P <
.001. TPT, transpulmonary thermodilution; GCS, Glasgow coma scale.
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with this retrospective study. Another limitation is the fact that
we did not differentiate between or adjust for crystalloids ver-
sus synthetic colloids, since DCI has been associated with the
use of synthetic colloids.29,35 However, these compounds were
administered mainly in case of clinical deteriorations due to
DCI as per our protocol at the time of the study period and not
typically in the first 3 days when fluid data were collected for
this study. Furthermore, we did not adjust fluid parameters for
weight. In cohort 2, due to the variable start of the TPT proto-
col, in relation to clinical admission, missing/unavailable val-
ues were unavoidable (eg, when TPT was initiated soon after
admission). Finally, our institutional fluid management proto-
col used in cohort 2 is based on our best clinical practice and
the scarce literature available33,34 but has not been validated
outside our ICU. The patients in cohort 2 are those more likely
to develop DCI, so the generalizability of our protocol to low-
risk patients with aSAH is uncertain. Because both cohorts are
from a single center and due to the sample size used, the overall
generalizability may be limited.
The strengths of our study include a consecutive series of
patients managed at an ICU with detailed data on fluid
management and prognostic factors as well as assessment of
the primary outcome (DCI) according to recently proposed
criteria.1,16 Second, we imputed missing data, with multiple
imputations enhancing the statistical power. Finally, our data
are in line with the recent notion that excessive fluid input is
an established risk factor for adverse outcome in nonneurolo-
gical critically ill patients36 and patients with aSAH in
particular.11,29,33,34,37
A guideline endorsed by the American Heart Association
advised to maintain euvolemia.5 However, establishing euvo-
lemia is difficult when clear definitions are absent. This is
reflected by the fact that mean daily fluid input and fluid bal-
ance in cohort 1 exceeded the predefined targets in our insti-
tutional protocol. Similarly, the hemodynamic data in cohort 2
suggested patients were hypervolemic when TPT was initiated.
A multidisciplinary consensus statement recommended the use
of hemodynamic monitoring devices in aSAH, only in hemo-
dynamically unstable patients.38 A practical approach based on
previous literature10,39 and our results may be to aim for euvo-
lemia by giving 2.5 to 3.5 L/d in most patients with a fluid
balance around 0. Invasive monitoring may then be considered
in patients in whom deviations from euvolemia are suspected
and considered highly detrimental, or in case of signs of stress
cardiomyopathy, neurogenic pulmonary edema, excessive
diuresis, or progressive DCI. Of note, with monitoring, the
ambiguous term “euvolemia” might best be replaced by
“adequate preload.”
Conclusion
High early daily fluid input is associated with DCI after aSAH.
We showed the feasibility of a protocol using TPT to signifi-
cantly reduce fluid input and balance without negatively
impacting on preload parameters and GCS. Further study
seems warranted to determine whether and when hemodynamic
monitoring can help establishing both restricted fluid manage-
ment and improved clinical outcomes.
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